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Impact of withdrawal of Ritalin LA in 
the Western Cape
To the Editor: In 2008, the regional supply of Ritalin LA 
(long-acting methylphenidate) to children managed in the 
government sector was terminated after 2 years of access, 
returning to the immediate-release formulation. A specialist 
(FvBD) seeing children at the Red Cross Children’s Hospital 
and some special schools monitored 57 children with attention 
deficit hyperactivity disorder (ADHD). By the end of the first 
term on the immediate-release formulation, 46 (80%) had 
experienced unfavourable consequences related to medication 
change. Their academic marks plummeted and they spent 
more time in detention or being disciplined. Their deterioration 
in behaviour at home caused additional problems, leading to 
the parents of 5 children buying Ritalin LA privately. In 2 cases 
use of Ritalin LA was erratic owing to economic constraints, 
and the children were at times given the immediate-release 
formulation. This cohort represented a small proportion of the 
total number of children in the Western Cape for whom Ritalin 
was prescribed.
Problems experienced with the immediate-release 
medication are:
•    Given in 2 doses, it does not give a ‘smooth ride’. The 
children, and the adults in their environment, notice the dip 
in blood levels, with features of ADHD manifesting.
•    Older children, especially teenagers, have poor compliance 
with attending the school nurse for the second dose.1 In 
schools where there is no nurse and teachers are busy, it is 
even less likely that a second dose will be given. If the first 
dose was given by parents before school, the medication 
would wear off at around 10h45, leaving the child and his 
classmates to negotiate the remainder of the school day 
without medication.
•    An obstruction to compliance is the caution by teachers 
in administering a Schedule 6 medication without proper 
training about its legal and safety aspects.
•    Complications with storage and delivery of the drug are 
inevitable, with some children not receiving the medication 
or not receiving it at the correct time, especially in 
mainstream schools without a school nurse.
The decision not to provide Ritalin LA was based not on 
its efficacy but solely on financial grounds. The company 
submitted an elevated tender price considered unacceptably 
high by the provincial government; this emphasises the lack 
of equity towards government patients – and the lack of ethics 
that allows pharmaceutical companies autonomy in pricing 
products. In some ways, the province was left with no choice 
but to refuse to pay. The tragedy remains that the policy impact 
falls on children who are constrained from reaching their full 
potential. The cost of the product has since been revised, and 
we hope that it may again be made available. However, these 
events demonstrate the need for legislation whereby companies 
cannot dramatically adjust product prices at short notice.
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Task shifting in the public health  
sector – what is the evidence?
To the Editor: We read your editorial of May 20081 on task 
shifting in the public sector with great interest. With the 
chronic shortage of health professionals in the public health 
sector in South Africa and other countries in sub-Saharan 
Africa, task shifting is a very attractive strategy. This is 
especially true in the context of HIV/AIDS, which poses a 
significant threat to social security and food supplies in sub-
Saharan Africa. While the rational use of effective antiretroviral 
(ARV) medication has changed the course of the disease in 
well-resourced countries, the same is not true for resource-poor 
countries in sub-Saharan Africa, where a critical shortage of 
skilled health workers has limited the provision of life-saving 
ARV drugs to a large proportion of those who need them.2 
However, moving specific tasks from highly specialised health 
workers to less specialised ones in our resource-poor health 
care systems should be based on solid scientific evidence.3
We searched Medline, EMBASE and The Cochrane 
Library, and found three systematic reviews that assessed the 
effectiveness of doctor-nurse substitution in the provision 
of care at the primary level.4-6 These reviews synthesised 
currently available randomised controlled trials (RCTs) and 
controlled before-and-after studies, and found that unselected 
patients (coming to either primary care facilities or emergency 
departments) were more satisfied with care from a nurse 
than from a doctor; but there were no appreciable differences 
between doctors and nurses in patient health outcomes, the 
care process, resource utilisation or cost. These systematic 
reviews provide the scientific basis for task shifting at the 
primary care level. However, the studies included in these 
systematic reviews were conducted in high-income countries 
in Western Europe and North America and did not provide 
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